Übersicht · Eingereicht: 2. Jan. 2024
UPC_CoA_2/2024
PROSTHETIC VALVE CRIMPING DEVICE
BerufungenHauptberufungCourt of AppealAppealCase Closed
Parteien
Kläger
- Edwards Lifesciences Corporation(Edwards Lifesciences Group)
Vertreter: Boris Kreye (Bird & Bird); Anika Boche (Bird & Bird)
Beklagte
- Meril GmbH(Meril Group)
- Meril Life Sciences Pvt Ltd.(Meril Group)
Vertreter: Andreas von Falck (Hogan Lovells International LLP); Roman Würtenberger (Hogan Lovells International LLP); Beatrice Wilden (Hogan Lovells International LLP)
Richter
- Klaus Grabinski
- Peter Blok
- Emanuela Germano
- Bernard Ledeboer
- Stefan Wilhelm
Patente
- EP3763331
- EP 3 763 331
CPC-Codes: B30B7/04, A61F2/9524, A61F2/9522, A61F2/2475, A61F2/2412, A61F2/2433, B25B27/10
Sektor: Pharmaceutical & Medical
Ausgang
Nur Kosten
Eingereicht: 2. Jan. 2024
Erste Entscheidung: 15. Feb. 2024
Sprache: German
Procedural order of the Court of Appeal addressing the appeal fee in an appeal by Meril GmbH and Meril Life Sciences against a Munich Local Division order in provisional measures proceedings brought by Edwards Lifesciences Corporation regarding EP 3 763 331 (crimping device for heart valve prostheses). After Meril submitted a cease-and-desist undertaking, Edwards accepted it and the case was resolved without a ruling. The first-instance court ordered Meril to bear costs up to EUR 200,000 and set the action value at EUR 1,500,000. Meril appealed. The Court of Appeal order concerned procedural aspects of the appeal fee payment.
Im UPC-Register öffnen